WRBY

ANALYST NOTE: WRBY (Warby Parker Inc.) Date: 2026-06-20 Analyst: StoryStocks-Native Equity Research

1. Structural Readiness

As of the close on 2026-06-20, WRBY is trading at $27.67. The setup is classified as a confirmed coil, indicating that the breakout signal has fired and the structural base is active. The conservative entry level for this confirmed setup is $30.11.

The current price of $27.67 represents an extension of -8.1% relative to the conservative entry. While the price is currently below the entry threshold, the "confirmed" status of the coil implies the structural formation has already occurred and the market has tested the breakout zone. The ATR at the time of the breakout was 6.4% (categorized as *very_high*), and the current ATR is 6.5% (*very_high*). This elevated volatility profile suggests significant structural quality and active participation, though it necessitates careful position sizing to account for the wider price swings inherent in this volatility bucket. The setup is not "forming" in the sense of waiting for a breakout; the breakout event has occurred, and the stock is currently trading within the post-breakout consolidation or retest phase.

2. The Thesis Layer

At this date, WRBY is a TACTICAL, setup-led name. There is no named secular thesis attached to this specific setup in the current framework. The investment case is not derived from a broad macroeconomic theme or a specific long-term industry shift (such as a "Silver Tsunami" or "AI Revolution" thesis) but is instead driven by the quality of the technical structure (the confirmed coil) and the immediate business fundamentals reported by management. The conviction must be weighed strictly on the setup quality and the operational evidence provided in the recent filings, without attributing external narrative weight that is not present in the data.

3. The Business

Warby Parker operates an integrated, omnichannel platform selling prescription eyewear, contact lenses, and eye care services. As of March 31, 2026, the company operates 337 retail stores in the U.S., having opened 14 net new stores in the first quarter of 2026. The business model relies on a direct-to-consumer approach, designing glasses in-house in New York City and selling them at a unified price point starting at $95, including prescription lenses.

Financial Performance & Guidance (as of Q1 2026 Earnings, May 7, 2026):

• Revenue: For the full year 2026, management reaffirmed guidance of $959 million to $976 million, representing 10% to 12% year-over-year growth.
• Profitability: Adjusted EBITDA is guided for $117 million to $119 million, implying an adjusted EBITDA margin of 12.2% (a 130 basis point expansion year-over-year).
• Q2 Outlook: Management guided Q2 2026 revenue to $235 million to $238 million (10-11% growth) and Adjusted EBITDA to $27 million to $29 million (approx. 12% margin).
• Customer Metrics: Active customers increased 4.8%, and Average Revenue per Customer (ARPC) rose to $331 from $310 in the prior year.
• Insurance Penetration: In-network insurance penetration reached 10% in Q1, up from 8% the prior year.
• Strategic Initiatives: The company is preparing to launch its first line of AI-enabled glasses in partnership with Google and Samsung later in 2026. This launch is expected to be revenue-neutral for the current guidance but will incur known operating expenses. Google has committed up to $75 million for product development and commercialization costs, with an additional $75 million investment option available to Warby Parker.

4. Archetype and Conviction

Archetype: Growth Leader / Margin Inflector. The company demonstrates a clear trajectory of scaling revenue while simultaneously expanding margins (130 bps EBITDA expansion). The business is transitioning from a pure retail play to a hybrid model incorporating high-margin services (insurance, contacts) and future high-tech product lines (AI glasses).

Conviction Analysis:

• Thesis Strength: Moderate. The lack of a named secular thesis limits the "story" to the immediate execution of the business plan. However, the execution is strong, with double-digit growth and margin expansion.
• Evidence Quality: High. The evidence base is robust, consisting of primary earnings transcripts and SEC filings from May 2026, providing specific, quantified guidance and operational metrics.
• Structural Quality: High. The ATR of 6.4-6.5% places the stock in the *very_high* bucket. Historically, this indicates a stock with significant momentum and institutional interest, though it carries higher volatility risk. The "confirmed coil" status suggests the market has already priced in the initial breakout, and the current price action is a test of that structure.
• Rerating Potential: Moderate to High. The combination of consistent double-digit growth, margin expansion, and the imminent launch of a differentiated product (AI glasses) provides a catalyst for multiple expansion if the product launch is successful.
• Valuation Context: While specific P/E or P/S multiples are not provided in the evidence, the 10-12% growth rate combined with 12% EBITDA margins suggests a premium valuation is being supported by earnings growth. The stock is currently trading below the conservative entry, which may offer a risk-adjusted entry point if the coil structure holds.

5. Invalidations, Strengtheners, and Gaps

What would Strengthen the Case:

• Successful AI Launch: Confirmation that the Google/Samsung AI glasses launch proceeds as planned without significant delays or technical hurdles.
• Insurance Growth: Continued acceleration in in-network insurance penetration beyond the 10% level, indicating deeper market penetration.
• Margin Expansion: Actual Q2 results exceeding the 12% EBITDA margin guidance, validating the operating leverage story.

What would Invalidate the Case:

• Guidance Cut: Any reduction in full-year 2026 revenue or EBITDA guidance, particularly if driven by the AI launch costs or consumer weakness.
• Store Closure: A net reduction in store count or a significant slowdown in new store openings (currently targeting 50 for the year).
• Customer Churn: A decline in Active Customers or ARPC, signaling a loss of pricing power or brand relevance.

Gaps in Evidence:

• AI Product Specifics: While the partnership is confirmed, there is no evidence regarding the specific pricing, features, or consumer reception of the AI glasses prior to launch.
• Contact Lens Penetration: Contact lenses contributed only 11.1% to net revenue in 2025. The evidence does not detail the growth trajectory or margin profile of this specific segment relative to the overall business.
• Competitive Landscape: No specific data on competitor actions or market share shifts in the $70 billion U.S. eyewear market is provided in the evidence.

PRIVATE ANALYST CALL

Judgment: Buy Confidence: medium Key evidence: Confirmed coil setup with very high ATR indicating strong structural momentum; Reaffirmed full-year guidance of $959M-$976M revenue with 10-12% growth and 130 bps EBITDA margin expansion; Strategic partnership with Google/Samsung for AI glasses launch later in 2026 with $75M development funding. Key risks: Current price is 8.1% below conservative entry, indicating immediate downside risk if support fails; Very high ATR (6.5%) suggests elevated volatility and potential for sharp drawdowns; AI glasses launch is a binary event with no revenue contribution in current guidance, creating execution risk; Insider selling by Co-CEO and Director in May/June 2026. Rating boundary: This is rated Buy rather than Strong Buy because the stock is currently trading below the conservative entry level, meaning the immediate risk/reward is not yet optimized for a maximum conviction position; the absence of a named secular thesis also limits the conviction ceiling compared to a thematic leader. It is rated Buy rather than Speculative because the business fundamentals are robust with clear, reaffirmed guidance and margin expansion, providing a solid operational floor. Sizing hint: Position size should be calibrated to the very high ATR; consider a smaller initial position to manage the 8% extension below entry, with plans to add on a confirmed retest of the $30.11 level or a breakout above it. Expected path: Management expects the AI glasses launch to occur later in 2026, with revenue contribution expected post-launch. The business is on track to open 50 stores in 2026, and insurance penetration is expected to continue growing. Expected horizon: 6 to 12 months, aligning with the full-year 2026 guidance period and the anticipated AI product launch. Failure mode to watch: A cut in full-year 2026 guidance or a significant miss on Q2 earnings, which would signal that the margin expansion story is breaking or consumer demand is weakening.